Literature DB >> 31356990

Plasticity at the DNA recognition site of the MeCP2 mCG-binding domain.

Ming Lei1, Wolfram Tempel2, Sizhuo Chen3, Ke Liu4, Jinrong Min5.   

Abstract

MeCP2 is an abundant protein, involved in transcriptional repression by binding to CG and non-CG methylated DNA. However, MeCP2 might also function as a transcription activator as MeCP2 is found bound to sparsely methylated promoters of actively expressed genes. Furthermore, Attachment Region Binding Protein (ARBP), the chicken ortholog of MeCP2, has been reported to bind to Matrix/scaffold attachment regions (MARs/SARs) DNA with an unmethylated 5'-CAC/GTG-3' consensus sequence. In our previous study, although we have systemically measured the binding abilities of MBDs to unmethylated CAC/GTG DNA and the complex structures reveal that the MBD2-MBD (MBD of MBD2) binds to the unmethylated CAC/GTG DNA by recognizing the complementary GTG trinucleotide, how the MeCP2-MBD (MBD of MeCP2) recognizes the unmethylated CAC/GTG DNA, especially the MARs DNA, is still unclear. In this study, we investigated the binding characteristics of MeCP2 in recognizing unmethylated 5'-CAC/GTG-3' motif containing DNA by binding and structural studies. We found that MeCP2-MBD binds to MARs DNA with a comparable binding affinity to mCG DNA, and the MeCP2-CAC/GTG complex structure revealed that MeCP2 residues R111 and R133 form base-specific interactions with the GTG motif. For comparison, we also determined crystal structures of the MeCP2-MBD bound to mCG and mCAC/GTG DNA, respectively. Together, these crystal structures illustrate the adaptability of the MeCP2-MBD toward the GTG motif as well as the mCG DNA, and also provide structural basis of a biological role of MeCP2 as a transcription activator and its disease implications in Rett syndrome.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  GTG containing DNA; MARs; MeCP2; Non-CG methylated DNA; Rett syndrome; X-ray crystallography

Mesh:

Substances:

Year:  2019        PMID: 31356990     DOI: 10.1016/j.bbagrm.2019.194409

Source DB:  PubMed          Journal:  Biochim Biophys Acta Gene Regul Mech        ISSN: 1874-9399            Impact factor:   4.490


  7 in total

Review 1.  Emerging Insights into the Distinctive Neuronal Methylome.

Authors:  Adam W Clemens; Harrison W Gabel
Journal:  Trends Genet       Date:  2020-08-21       Impact factor: 11.639

2.  Crystal structure of the BAZ2B TAM domain.

Authors:  Yingying Feng; Sizhuo Chen; Mengqi Zhou; Jin Zhang; Jinrong Min; Ke Liu
Journal:  Heliyon       Date:  2022-07-06

3.  Neuronal non-CG methylation is an essential target for MeCP2 function.

Authors:  Rebekah Tillotson; Justyna Cholewa-Waclaw; Kashyap Chhatbar; John C Connelly; Sophie A Kirschner; Shaun Webb; Martha V Koerner; Jim Selfridge; David A Kelly; Dina De Sousa; Kyla Brown; Matthew J Lyst; Skirmantas Kriaucionis; Adrian Bird
Journal:  Mol Cell       Date:  2021-02-08       Impact factor: 17.970

4.  A critique of the hypothesis that CA repeats are primary targets of neuronal MeCP2.

Authors:  Kashyap Chhatbar; John Connelly; Shaun Webb; Skirmantas Kriaucionis; Adrian Bird
Journal:  Life Sci Alliance       Date:  2022-09-19

5.  Absence of MeCP2 binding to non-methylated GT-rich sequences in vivo.

Authors:  John C Connelly; Justyna Cholewa-Waclaw; Shaun Webb; Verdiana Steccanella; Bartlomiej Waclaw; Adrian Bird
Journal:  Nucleic Acids Res       Date:  2020-04-17       Impact factor: 16.971

6.  In silico structural analysis of sequences containing 5-hydroxymethylcytosine reveals its potential as binding regulator for development, ageing and cancer-related transcription factors.

Authors:  Andigoni Malousi; Alexandra-Zoi Andreou; Sofia Kouidou
Journal:  Epigenetics       Date:  2020-09-02       Impact factor: 4.528

7.  A prelude to the proximity interaction mapping of CXXC5.

Authors:  Gamze Ayaz; Gizem Turan; Çağla Ece Olgun; Pelin Yaşar; Gizem Kars; Burcu Karakaya; Kerim Yavuz; Öykü Deniz Demiralay; Tolga Can; Mesut Muyan
Journal:  Sci Rep       Date:  2021-09-02       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.